tiprankstipranks
Assertio Therapeutics Inc (ASRT)
NASDAQ:ASRT
US Market

Assertio Therapeutics (ASRT) Income Statement

Compare
1,115 Followers

Assertio Therapeutics Income Statement

Last quarter (Q4 2024), Assertio Therapeutics's total revenue was $32.18M, a decrease of -2.43% from the same quarter last year. In Q4, Assertio Therapeutics's net income was $-10.48M. See Assertio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 124.96M$ 152.07M$ 156.23M$ 111.01M$ 106.28M
Gross Profit
$ 85.73M$ 125.05M$ 137.49M$ 95.18M$ 86.40M
Operating Expenses
$ 110.21M$ 368.58M$ 79.39M$ 84.67M$ 133.32M
Depreciation and Amortization
$ 0.00$ 28.23M$ 33.41M$ 29.11M$ 26.38M
EBITDA
$ -24.48M$ -222.45M$ 72.53M$ 38.78M$ -3.20M
Operating Income
$ -24.48M$ -243.54M$ 57.81M$ 9.42M$ -46.92M
Other Income/Expenses
$ 2.95M$ -10.52M$ -26.65M$ -9.98M$ 36.64M
Pretax Income
$ -21.53M$ -254.05M$ 31.17M$ -553.00K$ -45.51M
Net Income
$ -21.48M$ -331.94M$ 109.63M$ -1.28M$ -28.14M
Per Share Metrics
Basic EPS
$ -0.23$ -4.67$ 2.33$ -0.03$ -1.07
Diluted EPS
$ -0.23$ -4.67$ 2.01$ -0.03$ -1.07
Weighted Average Shares Outstanding
95.27M 71.03M 47.00M 43.17M 26.21M
Weighted Average Shares Outstanding (Diluted)
95.27M 71.03M 54.67M 43.17M 26.21M
Currency in USD

Assertio Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis